Dividend investing for retirement Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dividend investing for retirement

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

To: E_K_S who wrote (33179)	10/30/2020 9:31:11 AM
From: CusterInvestor	5 Recommendations of 34328

Even better, they raised guidance: AbbVie (NYSE: ABBV): Q3 Non-GAAP EPS of $2.83 beats by $0.06; GAAP EPS of $1.29 misses by $0.13. Revenue of $12.9B (+52.1% Y/Y) beats by $190M. Non-GAAP gross margin of 81.7%. Non-GAAP operating margin 48.8%. FY20 Guidance: Raised its GAAP EPS guidance from $4.12 to $4.22 to $3.89 to $3.91, which includes the results of Allergan from May 8, 2020 through December 31, 2020. Raised its adjusted EPS guidance from $10.35 to $10.45 to $10.47 to $10.49, which includes the results of Allergan from May 8, 2020 through December 31, 2020, representing annualized net accretion from the Allergan transaction of 12 percent. The combined company's adjusted EPS guidance excludes $6.58 per share of intangible asset amortization expense, non-cash charges for contingent consideration adjustments and other specified items.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next